More Encouraging Data on Ticagrelor Reversal Agent More Encouraging Data on Ticagrelor Reversal Agent
Bentracimab significantly restored platelet function, compared with placebo, in a phase 2b study of older volunteers treated with ticagrelor and aspirin.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 5, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19, JAMA Network
This study suggests that early aspirin use may be associated with lower odds of in-hospital mortality among hospitalized patients with moderate COVID-19; these findings warrant further study in a randomized clinical trial that includes diverse patients with cardiovascular comorbidities. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 31, 2022 Category: Consumer Health News Source Type: news
Early Aspirin Cuts In-Hospital Mortality With Moderate COVID-19
WEDNESDAY, March 30, 2022 -- Early aspirin use is associated with lower odds of 28-day in-hospital mortality among U.S. adults hospitalized with moderate COVID-19, according to a study published online March 24 in JAMA Network Open.
Jonathan H.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 30, 2022 Category: Pharmaceuticals Source Type: news
Is Aspirin the Best Way to Prevent Blood Clots After THA/TKA? Is Aspirin the Best Way to Prevent Blood Clots After THA/TKA?
Patients discharged to facilities rather than home may need more aggressive agents to prevent venous thromboembolism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2022 Category: Consumer Health News Tags: Orthopaedics News Source Type: news
Palliative Care in Assisted Living
Mrs. M is a 92-year-old woman residing in an assisted living community. Her medical history includes hypertension, gout, hyperlipidemia, atrial fibrillation, hypothyroidism, and melanoma with invasion into the parotid gland; she has had removal of a lesion and a parotidectomy with nerve involvement impacting the 7th cranial nerve. Her medications include oral levothyroxine, 100 μg daily; oral vitamin D, 1,000 units daily; oral probenecid 500/colchicine, 0.5 mg daily; oral lisinopril, 5 mg daily; oral furosemide, 20 mg daily; oral duloxetine, 60 mg for depression; oral carvedilol, 6.25 mg twice a day; oral aspirin, 81 mg d...
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news
The Aspirin Controversy Continues Despite New Guidelines Regarding Aspirin Usage in Older Adults
For many years, it was thought that an aspirin a day may keep the doctor away. This age-old sentiment has been put to the test in the past decade. (Source: Caring for the Ages)
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Angela M. Sanford, Milta O. Little Source Type: news
Aspirin may improve 3-month survival for patients critically ill with COVID-19, Imperial College London
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 24, 2022 Category: Consumer Health News Source Type: news
Could Aspirin Cut Death Risk for Hospitalized COVID Patients?
THURSDAY, March 24, 2022 -- Something as simple as aspirin may help lower the risk of death in hospital patients who are fighting a tough case of COVID-19, a new study found.
George Washington University researchers analyzed data on more than... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 24, 2022 Category: General Medicine Source Type: news
Aspirin Improves Survival For Hospitalized Covid Patients, Study Finds
Patients who were given aspirin soon after being admitted to hospital with Covid-19 were nearly 14% less likely to die in hospital within 28 days, researchers found. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 24, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Aspirin may reduce death In hospitalized COVID-19 patients
Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate COVID-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin. (Source: World Pharma News)
Source: World Pharma News - March 24, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Aspirin may improve 3-month survival for patients critically ill with COVID-19
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months according to a new international study led in the UK by researchers at the University of Bristol and Imperial College London. (Source: University of Bristol news)
Source: University of Bristol news - March 22, 2022 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Translational Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
Aspirin: Four sensations indicative of a developing stomach ulcer - 'visit your GP'
ASPIRIN is an everyday painkiller, used for a variety of ailments from toothache to flu-like symptoms. However, using it too regularly could lead to a stomach ulcer. (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2022 Category: Consumer Health News Source Type: news
Questions Remain About Safety of Aspirin Cessation in Older Adults
MONDAY, March 14, 2022 -- A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either cessation or continuation of aspirin in older adults who regularly use aspirin without a clinical indication for its... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2022 Category: Pharmaceuticals Source Type: news
The Truth About Common Digestive Health Fears
Everyone experiences digestive problems now and then, and they’re nobody’s idea of a good time. In a survey of nearly 72,000 adults in the U.S., 61% reported having had at least one gastrointestinal (GI) symptom over the previous week, and within that group, 58% said they’d had two or more GI symptoms over the past week, according to a study in a 2018 issue of the American Journal of Gastroenterology. Because symptoms like constipation, heartburn, and abdominal pain are generally vague and often don’t have an obvious cause, those suffering tend to fear the worst.
“People get very concerned abo...
Source: TIME: Health - March 14, 2022 Category: Consumer Health News Authors: Stacey Colino Tags: Uncategorized healthscienceclimate Source Type: news
